China’s Sinovac Biotech is starting Phase III trials of its potential coronavirus vaccine in Brazil, it said on Monday, becoming one of three companies to move into the late stages in the race to develop an inoculation against the disease.
US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing vaccines for mosquito-borne virus dengue fever.